A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Clinical trial NCT06137768 · COMPLETED

Trial details

NCT number: NCT06137768
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary IgA Nephropathy

Start date: 2023-12-19
Primary completion: 2025-10-17
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.